SN 38 has been used in trials studying the treatment of Cancer, Advanced Solid Tumors, Small Cell Lung Cancer, Metastatic Colorectal Cancer, and Triple Negative Breast Cancer, among others. 7-ethyl-10-hydroxycamptothecin (SN 38) is a liposomal formulation of the active metabolite of Irinotecan [DB00762], a chemotherapeutic pro-drug approved for the treatment of advanced colorectal cancer.
7-Ethyl-10-hydroxycamptothecin
| API Name | Irinotecan |
|---|---|
| CAS No | 86639-52-3 |
| Molecular Formula | C22H20N2O5 |
| Molecular Weight | 392.4 g/mol |
| Synonyms | (19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,1 -Show More |
Zoho Contact Form - Pharma Intermediates
"*" indicates required fields
Frequently Asked Questions
SN 38 has been used in trials studying the treatment of Cancer, Advanced Solid Tumors, Small Cell Lung Cancer, Metastatic Colorectal Cancer, and Triple Negative Breast Cancer, among others. 7-ethyl-10-hydroxycamptothecin (SN 38) is a liposomal formulation of the active metabolite of Irinotecan [DB00762], a chemotherapeutic pro-drug approved for the treatment of advanced colorectal cancer.
The CAS number of 7-Ethyl-10-hydroxycamptothecin is 86639-52-3.
The molecular formula of 7-Ethyl-10-hydroxycamptothecin is C22H20N2O5.
The listed molecular weight of 7-Ethyl-10-hydroxycamptothecin is 392.4 g/mol.
7-Ethyl-10-hydroxycamptothecin is listed as being used in connection with the following API: Irinotecan.
The listed synonym or IUPAC name for 7-Ethyl-10-hydroxycamptothecin is (19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,1 -Show More.